About US
Contact us
-
Roche's Gazyvaro gets EMA recommendation to treat rare white blood cell cancerThe European Medicines Agency (EMA) has recommended the extension of the authorised indication of Roche's Gazyvaro (obinutuzumab) to treat patients affected with follicular lymphoma. Gazyvaro must be2016/5/6
-
New KISS Lab Circulators on display at AnalyticaAt Analytica International Trade Fair and Conference, Huber will be showcasing its new solutions and further developments in temperature control for the research laboratory and process industries. Vi2016/5/6
-
NICE recommends Sanofi's Praluent as an effective treatment for bad cholesterolFrench pharmaceutical company Sanofi's Praluent (alirocumab) has been recommended by the National Institute for Health and Care Excellence (NICE) as an effective treatment option for people with inher2016/5/5
-
Report: Uncertain economic environment to affect Italy’s pharmaceutical industryItaly's pharmaceutical industry is set to decline by 2020 owing to its struggling economy, according to a new report published by GlobalData. Registering a negative compound annual growth rate of 3.3%2016/5/5
-
Biogen's Daclizumab receives positive opinion to treat multiple sclerosisUS biotechnology company Biogen has announced new data that reveals daclizumab's positive cognitive outcomes, targeted and reversible mechanism of action (MOA), and safety profile in patients sufferin2016/5/4
-
UK's CRT Pioneer Fund invests in research to develop HSF1 drugs for cancerUK's Cancer Research Technology (CRT) Pioneer Fund has invested in research to develop new drugs known as heat-shock factor 1 (HSF1) pathway inhibitors, which would be able to block a protective mecha2016/5/4
-
UK's PolyPhotonix launches sleep mask to treat diabetic retinopathyUK health technology company PolyPhotonix has unveiled its latest treatment for diabetic retinopathy that causes blindness among working-age adults. The new Noctura400 sleep mask launched in the coun2016/5/3
-
EMA recommends Zavicefta to treat multi-drug resistant bacteria in EUThe European Medicines Agency (EMA) has proposed that a marketing authorisation can be granted for Zavicefta (ceftazidime / avibactam) in the European Union (EU). New treatment option Zavicefta is a2016/5/3
-
Johnson & Johnson to acquire dermocosmetics company NeoStrataNew Jersey-based Johnson & Johnson Consumer has entered into a definitive agreement to purchase US dermocosmetics company, NeoStrata. The acquisition will include NeoStrata's affiliates and its p2016/4/29
-
Zymeworks partners with GSK to develop bi-specific antibodiesPrivately-held biotherapeutics company Zymeworks has entered into a licensing agreement with GlaxoSmithKline Pharmaceuticals (GSK) to research, develop and market bi-specific antibodies. Bi-specific2016/4/29